Brielle Benyon

From the San Francisco 49ers’ Trent Williams looking back on his cancer experience to a Republican congressman returning to work after myeloma treatment, here’s what’s happening in the oncology space this week.

An expert said that he is optimistic about the future use of biomarkers in the kidney cancer space.

The Food and Drug Administration granted a priority review to Blincyto for the treatment of early-stage CD19-positive B-cell acute lymphoblastic leukemia.

The Food and Drug Administration granted a Fast Track designation to the novel drug, ARV-471 for patients with metastatic or locally advanced ER-positive, HER2-negative breast cancer.

Certain antihypertensive medications may lower blood pressure in patients with blood cancer being treated with Imbruvica or other BTK inhibitors.

There are a few conversations patients should have with their care teams after being diagnosed with bladder cancer — especially as new treatments become more available.

One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.

In honor of World Cancer Day, we highlighted ongoing and successful advocacy efforts in the oncology space.

From Kristen Dahlgren stepping away from NBC to focus on the Pink Eraser Project for cancer vaccines, to MTV’s Jared March dying of sarcoma, here’s what is happening in the oncology space this week.

The 21-gene breast recurrence score may lead clinicians away from prescribing chemotherapy to Black women who could benefit from the therapy.

There were certain characteristics associated with a perceived loss of dignity in patients with cancer, according to recent research.

Here are some of the top stories from the recent Gastrointestinal Cancers Symposium as well as the Genitourinary Cancers Symposium.

The Food and Drug Administration will speed up their review of Enhertu for previously treated patients with certain HER2-positive solid tumors.

Subcutaneous Opdivo led to similar outcomes to intravenous administration of the drug and may be easier to access down the road, an expert said.

CURE® editors discuss last week’s biggest cancer headlines, from Dexter Scott King’s death to the potential of laughter therapy to boost quality of life.

Patients with bladder cancer being treated with the immunotherapy agent, Keytruda, should not hesitate to call their oncology team if something does not feel right, an expert said.

Approximately 40% of patients with metastatic castration-resistant prostate cancer did not undergo certain types of tests that can be instrumental in treatment decisions.

From the Duchess of York receiving a skin cancer diagnosis to Selena Gomez contacting a fan with stage 4 disease, here’s what is happening in the oncology space this week.

A CAR NK therapy made from cord blood showed promising responses in patients with relapsed or refractory B-cell malignancies.

Circulating tumor DNA can be a valuable tool in gastric cancer, but unanswered questions remain, an expert said.

The Food and Drug Administration is requesting that CAR-T cell therapies now come with a Boxed Warning about secondary malignancies that have been reported in patients who undergo these treatments.

Older adults with gastric cancer tended to have better outcomes when they walked 2,500 steps per day or more.

Dexter Scott King, son of Martin Luther King, Jr., died of prostate cancer the same day MLB Hall-of-Famer Ryan Sandberg announced he’s been diagnosed with metastatic disease.

We take a look at the first FDA approval in the oncology space for 2024, the Lymphedema Treatment Act and more.

The use of FOLFOXIRI for metastatic colorectal cancer was lower than one what expert was expecting.

Certain patients with metastatic colorectal cancer were more likely to have long-term remission to Stivarga treatment, recent research showed.

The FDA amended its approval for Balversa for the treatment of patients with locally advanced or metastatic bladder cancer.

From Broadway actor Jeff Gorti opening up about his childhood cancer experience to Brian Barczyk of The Reptarium dying, here’s what’s happening in the oncology space this week.

Certain tumor characteristics were predictive of which patients with lymphoma may have better outcomes with the CAR-T cell therapy, Yescarta.

The Lymphedema Treatment Act went into effect on Jan. 1, making prescribed lymphedema compression garments approved by Medicare Part B.